Please login to the form below
Alimta
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Alimta was produced by Lilly.
Merck chalks up another win for Keytruda in lung cancer
NSCLC). Interim data from the KEYNOTE-189 study showed that adding Keytruda to Eli Lilly’s Alimta (pemetrexed) plus a platinum drug improved both progression-free survival (PFS) and overall survival, ... The company hasn’t revealed the top-line data
Data backs up Roche’s Tecentriq/Avastin combo in lung cancer
Merck withdrew its EU filing for Keytruda as a first-line treatment for non-squamous NSCLC in combination with carboplatin and Eli Lilly's Alimta (pemetrexed) last month, saying it wanted
Lung cancer data gives Roche’s Tecentriq a boost
Merck pulled its EU filing for Keytruda as a first-line treatment for non-squamous NSCLC in combination with carboplatin and Eli Lilly's Alimta (pemetrexed) last month, saying it wanted
Merck pulls Keytruda filing in Europe, despite US approval
of Eli Lilly’s Alimta (pemetrexed) and carboplatin. ... That includes a revamped KeyNote-189 trial, which will look at overall survival with the combination of Keytruda, Alimta and carboplatin as front-line therapy in non-squamous NSCLC and is
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
- Editor – Medical Education Agency – Bucks
-
Salary TBC
-
Senior Programme Executive
-
Salary TBC
-
Senior Medical Writer
-
Great salary and bebefits
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- Account Manager – Med Comms – London
-
Salary TBC
-
Scientific Director
-
Great salary and bebefits
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
-
Senior Medical Writer
-
Great salary and benefits
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
Subscribe to our email news alerts
- BenevolentAI raises $115m to fund drug development
- Shire rebuffs Takeda bids, as Allergan bows out
- Abeona Therapeutics names CEO
- Zelluna Immunotherapy appoints chief technology officer
- Spirit Health Group offers new market access consultancy service
- Why heading online for scientific meetings can yield greater HCP engagement
PMHub
CACTUS
Founded in 2002, Cactus Communications is a fully integrated, global scholarly communications company with offices in Japan, South Korea, India,...
Latest intelligence
- Why heading online for scientific meetings can yield greater HCP engagement
- Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
- The threat of antimicrobial resistance
- Why this issue is such a fundamental challenge...
- Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
- Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Quick links
Infographics
